Dysregulated Expression of Adamalysin-Thrombospondin Genes in Human Breast Carcinoma

Clinical Cancer Research

Volumn 10, Issue 7, 2004, Pages 2429-2440

  Porter, Sarah ^a   Scott, Stuart D ^b   Sassoon, Elaine M ^b   Williams, Mark R ^a   Jones, J Louise ^c   Girling, Anne C ^b   Ball, Richard Y ^b   Edwards, Dylan R ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMALYSIN THROMBOSPONDIN PROTEINASE; ADAMTS15 PROTEINASE; DISINTEGRIN; METALLOPROTEINASE; PROTEINASE; PROTEOGLYCAN; UNCLASSIFIED DRUG;

ADAMTS GENE; ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST; BREAST CANCER; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GENETICS; CELL HETEROGENEITY; CLINICAL ARTICLE; DOWN REGULATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GONAD DEVELOPMENT; HUMAN; HUMAN TISSUE; MALIGNANT NEOPLASTIC DISEASE; MYOEPITHELIUM CELL; NUCLEOTIDE SEQUENCE; ORGANOGENESIS; PRIORITY JOURNAL; RNA ISOLATION; SURVIVAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AMINO ACID MOTIFS; BREAST; BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; DNA PRIMERS; DNA, COMPLEMENTARY; DOWN-REGULATION; EPITHELIUM; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; METALLOENDOPEPTIDASES; MIDDLE AGED; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PROGNOSIS; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; THROMBOSPONDINS; TIME FACTORS; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 1842479022     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-0398-3     Document Type: Article

References (50)

1. Tang BL. ADAMTS: a novel family of extracellular matrix proteases. Int J Biochem Cell Biol 200;33:33-44.
2. Cal S, Obaya AJ, Llamazares M, et al. Cloning, expression analysis, and structural characterization of seven human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains. Gene (Amst) 2002;283:49-62.
3. Nardi JB, Martos R, Walden KK, Lampe DJ, Robertson MH. Expression of lacunin, a large multidomain extracellular matrix protein, accompanies morphogenesis of epithelial monolayers in Manduca sexta. Insect Biochem Mol Biol 1999;29:883-97.
4. Zheng X, Chung D, Takayama TK, et al. Structure of Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem 2001;276:41059-63.
5. Kuno K, Matsushima K. ADAMTS-1 proteins anchors at the extracellular matrix through the thrombospondin type I motifs and its spacing region. J Biol Chem 1998;273:13912-7.
6. Kuno K, Kanada N, Nakashima E, et al. Molecular cloning of a gene encoding the new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J Biol Chem 1997;272:556-62.
7. Vazquez F, Hastings G, Ortega MA, et al. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J Biol Chem 1999;274:23349-57.
8. Robker RL, Russell DL, Espey LL, et al. Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases. Proc Natl Acad Sci USA 2000;97:4689-94.
9. Shindo T, Kurihara H, Kuno K, et al. ADAMTS-1: a metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function. J Clin Investig 2000;105:1345-52.
10. Colige A, Beschin A, Samyn B, et al. Characterization and partial amino acid sequencing of a 107-kDa procollagen I N-proteinase purified by affinity chromatography on immobilized type XIV collagen. J Biol Chem 1995;270:16724-30.
11. Colige A, Li SW, Sieron AL, et al. cDNA cloning and expression of bovine procollagen I N-proteinase: a new member of the superfamily if zinc-metalloproteinases with binding sites for cells and other matrix components. Proc Natl Acad Sci USA 1997;94:2374-9.
12. Colige A, Vandenberghe I, Thiry M, et al. Cloning and characterization of ADAMTS-14, a novel ADAMTS displaying high homology with ADAMTS-2 and ADAMTS-3. J Biol Chem 2002;277:5756-66.
13. Fernandes RJ, Hirohata S, Engle JM, et al. Procollagen II amino propeptide processing by ADAMTS-3. Insights on dermatosparaxis. J Biol Chem 2001;276:31502-9.
14. Colige A, Sieron AL, Li SW, et al. Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene. Am J Hum Genet 1999;65:308-17.
15. Li SW, Arita, M., Fertala A, et al. Transgenic mice with inactive alleles for procollagen N-proteinase (ADAMTS-2) develop fragile skin and male sterility. Biochem J 2001;355:271-8.
16. Kuno K, Okada Y, Kawashima H, et al. ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan. FEBS Lett 2000;478:241-5.
17. Tortorella MD, Burn TC, Pratta MA, et al. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science (Wash DC) 1999;284:1664-6.
18. Abbaszade I, Liu RQ, Yang F, et al. Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem 1999;274:23443-50.
19. Somerville RP, Longpre JM, Jungers KA, et al. Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1. J Biol Chem 2003;278:9503-13.
20. Yamanouchi. Yamanouchi Pharmaceutical Company, Japan, 2001.
21. Hurskainen TL, Hirohata S, Seldin MF, Apte SS. ADAM-TS5, ADAM-TS6, and ADAM-TS7, novel members of a new family of zinc metalloproteases. General features and genomic distribution of the ADAM-TS family. J Biol Chem 1999;274:25555-63.
22. Georgiadis KE, Hirohata S, Seldin MF, Apte SS. ADAM-TS8, a novel metalloproteinase of the ADAM-TS family located on mouse chromosome 9 and human chromosome 11. Genomics 1999;62:312-5.
23. Clark ME, Kelner GS, Turbeville LA, et al. ADAMTS9, a novel member of the ADAM-TS/metallospondin gene family. Genomics 2000;67:343-50.
24. Cal S, Arguelles JM, Fernandez PL, Lopez-Otin C. Identification, characterization, and intracellular processing of ADAM-TS12, a novel human disintegrin with a complex structural organization involving multiple thrombospondin-1 repeats. J Biol Chem 2001; 276:17932-40.
25. Fujikawa K, Suzuki H, McMullen B, Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood 2001;98:1662-6.
26. Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature (Lond) 2001;413:488-94.
27. Soejima K, Mimura N, Hirashima M, et al. A novel human metalloprotease synthesized in the liver and secreted into the blood possibly, the von Willebrand factor-cleaving protease? J Biochem (Tokyo) 2001; 130:475-80.
28. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science (Wash DC) 2002;295:2387-92.
29. Riddick ACP, Barker C, Sheriffs I, et al. Banking of fresh-frozen prostate tissue: methods, validation and use. BJU Int 2003;91:315-23.
30. Gomm JJ, Browne PJ, Coope RC, et al. Isolation of pure populations of epithelial and myoepithelial cells from the normal human mammary gland using immunomagnetic separation with Dynabeads. Anal Biochem 1997;226:91-9.
31. Stampfer M, Hallowes RC, Hackett AJ. Growth of normal human mammary cells in culture. In Vitro 1980;16:415-25.
32. Jones JL, Shaw JA, Pringle JH, Walker RA. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells. J Pathol 2003;201:562-72.
33. Runswick SK, O'Hare MJ, Jones JL, Streuli CH, Garrod DR. Desmosomal adhesion regulates epithelial morphogenesis and cell positioning. Nat Cell Biol 2001;3:823-30.
34. Wall SJ, Edwards DR. Quantitative reverse transcription-polymerase chain reaction (RT-PCR): a comparison of primer-dropping, compeptive, and real-time RT-PCRs. Anal Biochem 2002;300:269-73.
35. Kuno K, Iizasa H, Ohno S, Matsushima K. The exon/intron organization and chromosomal mapping of the mouse ADAMTS-1 gene encoding an ADAM family protein with TSP motifs. Genomics 1997; 46:466-71.
36. Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Wash DC) 1987;235:177-82.
37. Houston SJ, Plunkett TA, Barnes DM, et al. Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer. Br J Cancer 1999;79:1220-6.
38. Basset P, Wolf C, Chambon P. Expression of the stromelysin-3 gene in fibrolastic cells of invasive carcinomas of the breast and other human tissues: a review. Breast Cancer Res. Treat 1993;24: 185-93.
39. Kossakowska AE, Huchcroft SA, Urbanski SJ, Edwards DR. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans. Br J Cancer 1996;73:1401-8.
40. Hanemaaijer R, Verheijen JH, Maguire TM, et al. Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors. Int J Cancer 2000;86:204-7.
41. Nguyen M, Lee MC, Wang JL, et al. The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype. Oncogene 2000;19: 3449-59.
42. Masui T, Hosotani R, Tsuji S, et al. Expression of METH-1 and METH-2 in pancreatic cancer. Clin Cancer Res 2001;7:3437-43.
43. Iruela-Arispe ML, Porter P, Bornstein P, Sage EH. Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J Clin Investig 1996;97:403-12.
44. Gentile M, Wiman A, Thorstenson S, et al. Deletion mapping of chromosome segment 11q24-q25, exhibiting extensive allelic loss in early onset breast cancer. Int J Cancer 2001;92:208-13.
45. Martinez A, Walker RA, Shaw JA, et al. Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features. Mol Pathol 2001;54:300-6.
46. Koreth J, Bakkenist CJ, Larin Z, et al. 11q23.1 and 11q25-qter YACs suppress tumour growth in vivo. Oncogene 1999;18:1157-64.
47. Gentile M, Olsen K, Dufmats M, Wingren S. Frequent allelic losses at 11q24.1-q25 in young women with breast cancer: association with poor survival. Br J Cancer 1999;80:843-9.
48. Laforga JB, Aranda FI. Angiogenic index: a new method for assessing microvascularity in breast carcinoma with possible prognostic implications. Breast J 2000;6:103-7.
49. Wapnir IL, Barnard N, Wartenberg D, Greco RS. The inverse relationship between microvessel counts and tumor volume in breast cancer. Breast J 2001;7:184-8.
50. Carpizo D, Iruela-Arispe ML. Endogenous regulators of angiogenesis: emphasis on proteins with thrombospondin-type I motifs. Cancer Metastasis Rev 2000;19:159-65.